MIR182 is a microRNA implicated in various human cancers, where it often acts as an oncogene [PMC5308578]. In a study involving a reduced model with four predictors, MIR182 was one of the factors considered, alongside Age, miR21, and β-CTx [PMC9713074]. Overexpression of MIR182 has been observed to inhibit apoptosis in oral squamous cell carcinoma (OSCC) cells and conversely, its inhibition was shown to promote apoptosis in Tca8113 OSCC cells [PMC5308578]. MIR182 is not only upregulated in OSCC but also in several other cancers including breast cancer, where it is elevated both in tumor tissues and the serum of patients [PMC5308578]. Despite some controversy regarding its role in lung cancer, increased levels of MIR182 have been detected in lung cancer cells and tissues as well [PMC5308578'>PMC5308578]. Furthermore, upregulation of MIR182 has been documented across various other cancers such as melanoma, glioma tumors, ovarian cancer, colorectal cancer, and prostate cancer; this upregulation contributes to tumor cell survival and metastatic behaviors [PMC5308578]. The oncogenic function of MIR182 has been linked to its regulation of RASA1 and SPRED1 genes that are involved with Ras activation pathways within OSCC [PMC5308578].
ga - -u - c uU UGG UCA ugaggu gcug cu g ccuc ccccgu UUGGCAA UAGAAC CACUgg a |||| || | |||| |||||| ||||||| |||||| |||||| cggc ga c ggag gggguA AACCGUU AUCUUG GUggcc a ca c cu a c UC CAG --- uaggac
Name | Accession | Chromosome | Start | End | Strand | Confidence |
---|
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0000259 |
Description | Homo sapiens hsa-miR-182-5p mature miRNA |
Sequence | 23 - UUUGGCAAUGGUAGAACUCACACU - 46 |
Evidence |
experimental
cloned [2-3] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
Accession | MIMAT0000260 |
Description | Homo sapiens hsa-miR-182-3p mature miRNA |
Sequence | 67 - UGGUUCUAGACUUGCCAACUA - 87 |
Evidence | not_experimental |
|